Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Advanced therapy medicinal products (ATMPs) hold promise as treatments for previously untreatable and high-burden diseases. Expectations are high and active company pipelines are observed, yet only 10 market authorizations were approved in Europe. Our aim was to identify challenges experienced in Eu...

Descripción completa

Detalles Bibliográficos
Autores principales: ten Ham, Renske M.T., Hoekman, Jarno, Hövels, Anke M., Broekmans, Andre W., Leufkens, Hubert G.M., Klungel, Olaf H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234262/
https://www.ncbi.nlm.nih.gov/pubmed/30456217
http://dx.doi.org/10.1016/j.omtm.2018.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234262/
https://www.ncbi.nlm.nih.gov/pubmed/30456217
http://dx.doi.org/10.1016/j.omtm.2018.10.003

Ejemplares similares